What is Shanghai Fosun Pharmaceutical (Group) Co E10?
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.032. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.10 for the trailing ten years ended in Mar. 2024.
During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average E10 Growth Rate was -2.20% per year.
During the past 3 years, the average E10 Growth Rate was 4.70% per year.
During the past 5 years, the average E10 Growth Rate was 5.60% per year.
During the past 10 years, the average E10 Growth Rate was 8.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.
During the past 13 years, the highest 3-Year average E10 Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 15.90% per year. The lowest was 4.70% per year. And the median was 11.75% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shanghai Fosun Pharmaceutical (Group) Co E10 Chart
Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's E10
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry
* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio falls into.
Shanghai Fosun Pharmaceutical (Group) Co E10 Calculation
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.
What is E10? How do we calculate E10?
E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.
We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
per share eps
CPI
Adj_EPS
201406
0.042
98.200
0.049
201409
0.039
98.900
0.045
201412
0.037
99.000
0.043
201503
0.037
99.900
0.043
201506
0.053
99.500
0.061
201509
0.039
100.500
0.045
201512
0.037
100.600
0.042
201603
0.042
102.200
0.047
201606
0.058
101.400
0.066
201609
0.043
102.400
0.048
201612
0.038
102.600
0.043
201703
0.045
103.200
0.050
201706
0.056
103.100
0.063
201709
0.044
104.100
0.049
201712
0.042
104.500
0.046
201803
0.044
105.300
0.048
201806
0.054
104.900
0.059
201809
0.029
106.600
0.031
201812
0.035
106.500
0.038
201903
0.042
107.700
0.045
201906
0.045
107.700
0.048
201909
0.031
109.800
0.033
201912
0.070
111.200
0.073
202003
0.033
112.300
0.034
202006
0.062
110.400
0.065
202009
0.044
111.700
0.045
202012
0.070
111.500
0.072
202103
0.051
112.662
0.052
202106
0.100
111.769
0.103
202109
0.065
112.215
0.067
202112
0.072
113.108
0.073
202203
0.028
114.335
0.028
202206
0.063
114.558
0.063
202209
0.048
115.339
0.048
202212
0.070
115.116
0.070
202303
0.054
115.116
0.054
202306
0.042
114.558
0.042
202309
0.025
115.339
0.025
202312
0.004
114.781
0.004
202403
0.032
115.227
0.032
Add all the adjusted EPS together and divide 10 will get our e10.
Shanghai Fosun Pharmaceutical (Group) Co (OTCPK:SFOSF) E10 Explanation
If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.
For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.
The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Shanghai Fosun Pharmaceutical (Group) Co's Shiller P/E Ratio of today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
During the past 13 years, the highest Shiller P/E Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 68.81. The lowest was 16.30. And the median was 30.76.
Be Aware
Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.
Shanghai Fosun Pharmaceutical (Group) Co E10 Related Terms
Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Business Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SFOSF has been successfully added to your 